Your account is not claimed yet. You can sign up with ORCID to claim your account.

Xin-Rong Yang (Xinrong Yang)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 20

Top Venues

Signal transduction and targeted therapy

Clinical and translational medicine

Cells

Liver international : official journal of the International Association for the Study of the Liver

Zhongshan Hospital Fudan University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhongshan Hospital Fudan University Dec 2o 2019

China

Professor :: Department of Liver Surgery & Transplantation, Liver Cancer Institute

Publications

Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy 8 (1) (2023)
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy 8 (1) (2023)
Xiaoxiu Tan, Linfeng Xu, Xingxing Jian, Jian Ouyang, Bo Hu, Xin-Rong Yang, Tao Wang, Lu Xie
PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions. Cells 12 (5) (2023)
Xiaoxiu Tan, Linfeng Xu, Xingxing Jian, Jian Ouyang, Bo Hu, Xin-Rong Yang, Tao Wang, Lu Xie
PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions. Cells 12 (5) (2023)
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy 8 (1) (2023)
Liang Wu, Jiayan Yan, Yinqi Bai, Feiyu Chen, Xuanxuan Zou, Jiangshan Xu, Ao Huang, Liangzhen Hou, Yu Zhong, Zehua Jing, Qichao Yu, Xiaorui Zhou, Zhifeng Jiang, Chunqing Wang, Mengnan Cheng, Yuan Ji, Yingyong Hou, Rongkui Luo, Qinqin Li, Liang Wu, Jianwen Cheng, Pengxiang Wang, Dezhen Guo, Waidong Huang, Junjie Lei, Shang Liu, Yizhen Yan, Yiling Chen, Sha Liao, Yuxiang Li, Haixiang Sun, Na Yao, Xiangyu Zhang, Shiyu Zhang, Xi Chen, Yang Yu, Yao Li, Fengming Liu, Zheng Wang, Shaolai Zhou, Huanming Yang, Shuang Yang, Xue Liu, Longqi Liu, Qiang Gao, Zhaoyou Tang, Xiangdong Wang, Jian Wang, Jia Fan, Shi-Ping Liu, Xin-Rong Yang, Ao Chen, Jian Zhou
An invasive zone in human liver cancer identified by Stereo-seq promotes hepatocyte-tumor cell crosstalk, local immunosuppression and tumor progression. Cell research (2023)
Xiaoxiu Tan, Linfeng Xu, Xingxing Jian, Jian Ouyang, Bo Hu, Xin-Rong Yang, Tao Wang, Lu Xie
PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions. Cells 12 (5) (2023)
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study. Signal transduction and targeted therapy 8 (1) (2023)
An-Li Jin, Chun-Yan Zhang, Wen-Jing Zheng, Jing-Rong Xian, Wen-Jing Yang, Te Liu, Wei Chen, Tong Li, Bei-Li Wang, Bai-Shen Pan, Qian Li, Jian-Wen Cheng, Peng-Xiang Wang, Bo Hu, Jian Zhou, Jia Fan, Xin-Rong Yang, Wei Guo
CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis. Clinical and translational medicine 12 (4) (2022)
Shao-Lai Zhou, Zheng-Jun Zhou, Cheng-Li Song, Hao-Yang Xin, Zhi-Qiang Hu, Chu-Bin Luo, Yi-Jie Luo, Jia Li, Zhi Dai, Xin-Rong Yang, Ying-Hong Shi, Zheng Wang, Xiao-Wu Huang, Jia Fan, Jian Zhou
Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence. Signal transduction and targeted therapy 7 (1) (2022)
Yunfan Sun, Jian Zhou, Jia Fan, Xin-Rong Yang
Single-cell RNA sequencing reveals spatial heterogeneity and immune evasion of circulating tumor cells. Cancer biology & medicine 18 (4) (2022)
Bo Hu, Mincheng Yu, Xiaolu Ma, Jia-Lei Sun, Chenglong Liu, Chunyan Wang, Suiyi Wu, Pei-Yao Fu, Zhen Yang, Yungang He, Yuanyuan Zhu, Cheng Huang, Xin-Rong Yang, Yinghong Shi, Shuangjian Qiu, Huichuan Sun, Andrew X Zhu, Jian Zhou, Yang Xu, Di Zhu, Jia Fan
IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment. Cancer discovery 12 (7) (2022)
Lihua Lyu, Wenjing Yang, Jiayi Yao, Hao Wang, Jie Zhu, Anli Jin, Te Liu, Beili Wang, Jian Zhou, Jia Fan, Xin-Rong Yang, Wei Guo
The diagnostic value of plasma exosomal hsa_circ_0070396 for hepatocellular carcinoma. Biomarkers in medicine 15 (5) (2021)
De-Zhen Guo, Ao Huang, Yu-Peng Wang, Ya Cao, Jia Fan, Xin-Rong Yang, Jian Zhou
Development of an Eight-gene Prognostic Model for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Journal of clinical and translational hepatology 9 (6) (2021)
Xin Zhang, Bo Hu, Yun-Fan Sun, Xiao-Wu Huang, Jian-Wen Cheng, Ao Huang, Hai-Ying Zeng, Shuang-Jian Qiu, Ya Cao, Jia Fan, Jian Zhou, Xin-Rong Yang
Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. Clinical and translational medicine 11 (2) (2021)
Yun-Fan Sun, Liang Wu, Shi-Ping Liu, Miao-Miao Jiang, Bo Hu, Kai-Qian Zhou, Wei Guo, Yang Xu, Yu Zhong, Xiao-Rui Zhou, Ze-Fan Zhang, Geng Liu, Sheng Liu, Ying-Hong Shi, Yuan Ji, Min Du, Nan-Nan Li, Gui-Bo Li, Zhi-Kun Zhao, Xiao-Yun Huang, Li-Qin Xu, Qi-Chao Yu, David H Peng, Shuang-Jian Qiu, Hui-Chuan Sun, Michael Dean, Xiang-Dong Wang, Wen-Yuan Chung, Ashley R Dennison, Jian Zhou, Yong Hou, Jia Fan, Xin-Rong Yang
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma. Nature communications 12 (1) (2021)
Peng-Xiang Wang, Yun-Fan Sun, Kai-Qian Zhou, Jian-Wen Cheng, Bo Hu, Wei Guo, Yue Yin, Jun-Feng Huang, Jian Zhou, Jia Fan, Tan To Cheung, Xu-Dong Qu, Xin-Rong Yang
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched study. Clinical and translational medicine 10 (3) (2020)
Yun-Fan Sun, Peng-Xiang Wang, Jian-Wen Cheng, Zi-Jun Gong, Ao Huang, Kai-Qian Zhou, Bo Hu, Ping-Ting Gao, Ya Cao, Shuang-Jian Qiu, Jian Zhou, Jia Fan, Wei Guo, Xin-Rong Yang
Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection. Cancer cytopathology 128 (10) (2020)
Peng-Xiang Wang, Yang Xu, Yun-Fan Sun, Jian-Wen Cheng, Kai-Qian Zhou, Sui-Yi Wu, Bo Hu, Ze-Fan Zhang, Wei Guo, Ya Cao, Xiao-Wu Huang, Jian Zhou, Jia Fan, Xin-Rong Yang
Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation. Liver international : official journal of the International Association for the Study of the Liver 41 (3) (2020)
Peng-Xiang Wang, Yun-Fan Sun, Wei-Xiang Jin, Jian-Wen Cheng, Hai-Xiang Peng, Yang Xu, Kai-Qian Zhou, Li-Meng Chen, Kai Huang, Sui-Yi Wu, Bo Hu, Ze-Fan Zhang, Wei Guo, Ya Cao, Jian Zhou, Jia Fan, Xin-Rong Yang
Circulating tumor cell detection and single-cell analysis using an integrated workflow based on ChimeraX® -i120 Platform: A prospective study. Molecular oncology 15 (9) (2020)

Xin-Rong Yang.css-eqlu8i{font-size:small;padding-left:4px;} (Xinrong Yang)

Publication Activity (10 Years)

Top Topics

Top Venues

Xin-Rong Yang (Xinrong Yang)